Home
Live Updates
Dyadics C1 Platform Selected by the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital as Part of VICs $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases -October 05, 2023 at 08:32 am EDT : comparemela.com
Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts General Hospital as Part of VIC's $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases -October 05, 2023 at 08:32 am EDT
JUPITER, Fla., Oct. 05, 2023 -- Dyadic International, Inc. , a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein...
Related Keywords
Massachusetts ,
United States ,
Delaware ,
Mark Emalfarb ,
Mark Poznansky ,
Patrickj Gallagher ,
Voltron Therapeutics Inc ,
Us Department Of Defense Do ,
Immunotherapy Center At Massachusetts ,
Securities Exchange ,
Dyadic International Inc ,
Immunotherapy Center ,
Dyadic International ,
Massachusetts General Hospital ,
Voltron Therapeutics ,
Self Assembling Vaccine ,
Chief Executive ,
Massachusetts General ,
Emerging Infectious ,
Lassa Fever ,
Securities Act ,
Securities Exchange Act ,
Markets ,
comparemela.com © 2020. All Rights Reserved.